Collplant Biotechnologies LTCLGN

13F holders, Q3 2025 (September 30)
18holders +1
3new positions
2sold out
1famous investor
$2.69avg. 13F price*

At the end of Q3 2025, 18 institutions reported holding Collplant Biotechnologies LT (CLGN) in their 13F filings, up 1 from Q2 2025. 3 opened new positions and 2 sold out. The largest holders were Villere St Denis J & Co. LLC ($1.6M), Pinnacle Associates Ltd. ($1.4M) and AMH Equity Ltd ($538K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Collplant Biotechnologies LT
CUSIP
M2R51X116
Latest filing quarter
Q2 2026

History

Number of 13F holders

05101520 Q1 2024: 12Q1 2024Q2 2024: 15Q2 2024Q3 2024: 12Q3 2024Q4 2024: 13Q4 2024Q1 2025: 15Q1 2025Q2 2025: 17Q2 2025Q3 2025: 18Q3 2025Q4 2025: 16Q4 2025Q1 2026: 20Q1 2026Q2 2026: 15Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions3$28K
Exits2$231K

All 13F filers, Q2 2025 → Q3 2025: 101,491 shares bought and 464,682 shares sold, net −363,191 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 18 holders

Villere St Denis J & Co. LLC 0.16% Add +7.7% 588,717 $1.6M
Pinnacle Associates Ltd. 0.02% No change 507,193 $1.4M
AMH Equity Ltd 0.67% Add +24.3% 200,000 $538K
Brown Advisory Inc. 0.00% Add +6.8% 118,731 $319K
Renaissance Technologies 0.00% Reduce -47.4% 21,900 $59K
Heights Capital Management, Inc. 0.02% Reduce -93.0% 19,258 $52K
Pathstone Holdings, LLC 0.00% Reduce -50.0% 17,000 $46K
Waters Parkerson & Co., LLC 0.00% No change 13,250 $36K
Wells Fargo & Company 0.00% Reduce -19.4% 10,000 $27K
FNY Investment Advisers, LLC 0.00% New 5,250 $14K
Group One Trading LLC 0.00% New 5,000 $13K
Bank of America Corp. 0.00% No change 2,500 $7K
Morgan Stanley 0.00% Add +240500.0% 2,406 $6K
Osaic Holdings, Inc. 0.00% No change 335 $1K
Royal Bank of Canada 0.00% New 284 $1K
National Bank of Canada 0.00% No change 250 $670
SBI Securities Co., Ltd. 0.00% Add +0.5% 201 $541
Simplex Trading, LLC 0.00% Reduce -3.2% 90 $0

"% of holder's portfolio" is CLGN's weight in each manager's 13F, not the share of Collplant Biotechnologies LT the manager owns.